Impact of MRI and Targeted Biopsies on Eligibility and Disease Reclassification in MRI-positive Candidates for Active Surveillance on Systematic Biopsies

被引:0
|
作者
Gupta, Gopal N. [1 ]
Hart, Spencer [1 ]
机构
[1] Loyola Univ Med Ctr, Dept Urol, Urol Oncol, Maywood, IL 60153 USA
关键词
D O I
10.1016/j.urology.2019.10.043
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:131 / 132
页数:2
相关论文
共 50 条
  • [31] MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnosis of Localized Prostate Cancer in Biopsy Naive Men
    Peltier, Alexandre
    Aoun, Fouad
    Lemort, Marc
    Kwizera, Felix
    Paesmans, Marianne
    Van Velthoven, Roland
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [32] COMBINING MRI-US FUSION TARGETED BIOPSY WITH SYSTEMATIC BIOPSY IMPROVES RISK STRATIFICATION OF ACTIVE SURVEILLANCE CANDIDATES
    Meng, Xiaosong
    Rosenkrantz, Andrew B.
    Mendhiratta, Neil
    Guiffart, Pauline
    Huang, Richard
    Deng, Fang-Ming
    Zhou, Ming
    Melamed, Jonathan
    Huang, William C.
    Lepor, Herbert
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2016, 195 (04): : E232 - E233
  • [33] Optimized grade group for reporting prostate cancer grade in systematic and MRI-targeted biopsies
    He, Yang
    Shen, Qi
    Fu, Weixiao
    Wang, He
    Song, Gang
    PROSTATE, 2022, 82 (11): : 1125 - 1132
  • [34] MRI-guided targeted prostate biopsies in the diagnosis of prostate cancer: A systematic literature review
    Fiard, G.
    Descotes, J. -L.
    Rambeaud, J. -J.
    Hohn, N.
    Troccaz, J.
    Long, J. -A.
    PROGRES EN UROLOGIE, 2012, 22 (15): : 903 - 912
  • [35] Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for inter mediate risk prostate cancer patients
    Bloom, Jonathan B.
    Daneshvar, Michael A.
    Lebastchi, Amir H.
    Ahdoot, Michael
    Gold, Samuel A.
    Hale, Graham
    Mehralivand, Sherif
    Sanford, Thomas
    Valera, Vladimir
    Wood, Bradford J.
    Choyke, Peter L.
    Merino, Maria J.
    Turkbey, Baris
    Parnes, Howard L.
    Pinto, Peter A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 729.e1 - 729.e6
  • [36] The prognostic value of high-grade prostate cancer pattern on MRI-targeted biopsies: predictors for downgrading and importance of concomitant systematic biopsies
    Manceau, Cecile
    Fromont-Hankard, Gaelle
    Beauval, Jean-Baptiste
    Lesourd, Marine
    Almeras, Christophe
    Bajeot, Anne-Sophie
    Gautier, Jean-Romain
    Soulie, Michel
    Loison, Guillaume
    Salin, Ambroise
    Tollon, Christophe
    Malavaud, Bernard
    Roumiguie, Mathieu
    Ploussard, Guillaume
    WORLD JOURNAL OF UROLOGY, 2021, 39 (09) : 3315 - 3321
  • [37] The prognostic value of high-grade prostate cancer pattern on MRI-targeted biopsies: predictors for downgrading and importance of concomitant systematic biopsies
    Cécile Manceau
    Gaëlle Fromont-Hankard
    Jean-Baptiste Beauval
    Marine Lesourd
    Christophe Almeras
    Anne-Sophie Bajeot
    Jean-Romain Gautier
    Michel Soulié
    Guillaume Loison
    Ambroise Salin
    Christophe Tollon
    Bernard Malavaud
    Mathieu Roumiguié
    Guillaume Ploussard
    World Journal of Urology, 2021, 39 : 3315 - 3321
  • [38] OUTCOMES OF MRI-US FUSION TARGETED BIOPSY IN THE RISK STRATIFICATION OF ACTIVE SURVEILLANCE CANDIDATES
    Meng, Xiaosong
    Rosenkrantz, Andrew B.
    Mendhiratta, Neil
    Fenstermaker, Michael
    Huang, Richard
    Wysock, James
    Deng, Fang-Ming
    Melamed, Jonathan
    Zhou, Ming
    Huang, William C.
    Lepor, Herbert
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2015, 193 (04): : E754 - E755
  • [39] Optimized grade group for reporting prostate cancer grade in both systematic and MRI-targeted biopsies
    Song, G.
    He, Y.
    EUROPEAN UROLOGY, 2022, 81 : S928 - S928
  • [40] MRI-Guided Targeted and Systematic Prostate Biopsies as Prognostic Indicators for Prostate Cancer Treatment Decisions
    Abd Ali, Furat
    Sievert, Karl-Dietrich
    Eisenblaetter, Michel
    Titze, Barbara
    Hansen, Torsten
    Barth, Peter J.
    Titze, Ulf
    CANCERS, 2023, 15 (15)